BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32604116)

  • 21. Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT.
    Ribeiro TH; S R; Castro AC; Paulino E; Mamede M
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):109-111. PubMed ID: 28355370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple intraabdominal purulent collections demonstrated on FDG PET/CT in staging of non-Hodgkin lymphoma.
    Tow J; Loh H; Bui C; Fuller S; Mansberg R
    Clin Nucl Med; 2012 Feb; 37(2):210-3. PubMed ID: 22228357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.
    Atkinson W; Catana C; Abramson JS; Arabasz G; McDermott S; Catalano O; Muse V; Blake MA; Barnes J; Shelly M; Hochberg E; Rosen BR; Guimaraes AR
    Abdom Radiol (NY); 2016 Jul; 41(7):1338-48. PubMed ID: 27315095
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F18-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of vertebral vascular tumors.
    Song L; Han S; Jiang L; Zhang W
    Clin Imaging; 2020 Sep; 65():24-32. PubMed ID: 32353715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT.
    Kim DW; Kim WH; Kim CG
    Clin Nucl Med; 2013 May; 38(5):e233-5. PubMed ID: 23143046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal and diffuse FDG uptake patterns of endotracheal lymphoma.
    Dong A; Zhao T; Wang Y; Zuo C
    Clin Nucl Med; 2014 Aug; 39(8):731-5. PubMed ID: 24217549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
    Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased brain FDG uptake in patients with extensive non-Hodgkin's lymphoma lesions.
    Hanaoka K; Hosono M; Shimono T; Usami K; Komeya Y; Tsuchiya N; Yamazoe Y; Ishii K; Tatsumi Y; Sumita M
    Ann Nucl Med; 2010 Dec; 24(10):707-11. PubMed ID: 20824395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG PET/CT Findings of a Primary Paravertebral Liposarcoma.
    Wang R; Shen G; Tian R
    Clin Nucl Med; 2022 Jan; 47(1):70-72. PubMed ID: 34034329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
    Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
    Mittal BR; Manohar K; Malhotra P; Das R; Kashyap R; Bhattacharya A; Varma N; Varma S
    Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
    Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
    Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
    Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
    J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).
    Bernstine H; Domachevsky L; Nidam M; Goldberg N; Abadi-Korek I; Shpilberg O; Groshar D
    Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG PET/CT Image of Soft Tissue Aneurysmal Bone Cyst.
    Xiao L; Cheng J; Li L
    Clin Nucl Med; 2022 Oct; 47(10):e632-e634. PubMed ID: 35426845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18 F-FDG PET/CT of a Rare Sternal Osteoblastoma in a Man With History of Lymphoma.
    Liang J; Huang WS; Lan WZ; Li Y; Xu JH
    Clin Nucl Med; 2023 Apr; 48(4):324-326. PubMed ID: 36716503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET/CT in splenic marginal zone lymphoma.
    Albano D; Giubbini R; Bertagna F
    Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
    Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
    Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
    Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.